Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on S 1 Aminoindane. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105063164A reveals DKR method for S-6-Methoxy-1-Aminoindane. High purity and yield offer supply chain stability and cost efficiency for pharmaceutical intermediates manufacturing globally.
Patent CN105154514A enables high-purity (S)-5-methyl-1-aminoindane via dynamic kinetic resolution. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
This novel chiral resolution method offers high purity and significant cost efficiency for global pharmaceutical intermediate manufacturing supply chains today.
Patent CN105061219A enables high-purity S-1-aminoindane via D-mandelic acid resolution. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN105017035B details a high-purity DKR method for chiral intermediates. Achieves >99% ee with scalable catalysts for reliable pharmaceutical supply chains.